ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "surgery"

  • Abstract Number: 1805 • 2019 ACR/ARP Annual Meeting

    Perioperative Anti-rheumatic Medications Are Not Associated with 30-day Odds of Infection in Rheumatoid Arthritis Patients Undergoing Surgery: A Retrospective Cohort Study

    Marianne Kerski1, Peter Boersma 2, Eric Miller 3, Ashley Brenner 4, Genevieve Melton 5 and Anna Shmagel 6, 1University of Minnesota Medical School, Minneapolis, MN, 2University of Minnesota School of Public Health, Minneapolis, 3University of Minnesota, Woodbury, MN, 4University of Minnesota Best Practices Integrated Informatics Core (BPIC), Minneapolis, MN, 5University of Minnesota Department of Surgery, Minneapolis, MN, 6University of Minnesota, Minneapolis, MN

    Background/Purpose: Perioperative management of anti-rheumatic drugs in rheumatoid arthritis (RA) patients undergoing surgery remains controversial. Previous studies produced conflicting results, and data on non-orthopedic surgeries…
  • Abstract Number: 1892 • 2019 ACR/ARP Annual Meeting

    Association Between Rheumatoid Arthritis Treatment and the Risk of Death or Readmission After Major Surgery

    Michael George1, Joshua Baker 2, Kevin Winthrop 3, Lang Chen 4, Qufei Wu 2, Fenglong Xie 5 and Jeffrey Curtis 4, 1University of Pennsylvania, Philadelphia, 2University of Pennsylvania, Philadelphia, PA, 3Oregon Health and Science University, Portland, OR, 4University of Alabama at Birmingham, Birmingham, AL, 5University of Alabama at Birmingham, Birmingham

    Background/Purpose: The impact of immunosuppression on post-operative outcomes in rheumatoid arthritis (RA) has primarily been studied in patients undergoing joint replacement surgery. We aimed to…
  • Abstract Number: 2799 • 2019 ACR/ARP Annual Meeting

    Does Early Anterior Cruciate Ligament Reconstruction Prevent Further Meniscal Damage? Secondary Analysis of a Randomized Controlled Trial

    Barbara Snoeker 1, Frank Roemer 2, Aleksandra Turkiewicz 1, Stefan Lohmander 3, Richard Frobell 1 and Martin Englund1, 1Lund University, Lund, Sweden, 2University of Erlangen-Nuremberg, Erlangen, Germany, 3Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Lund, Sweden, Lund, Sweden

    Background/Purpose: It has been suggested that recurrent instability episodes in a non-reconstructed anterior cruciate ligament (ACL) injured knee increase the risk for an incident meniscal…
  • Abstract Number: 2872 • 2019 ACR/ARP Annual Meeting

    Risk of 30-day Readmission and Adverse Events After Primary Hip or Knee Arthroplasty: A Comparison of Patients with Rheumatoid Arthritis versus Osteoarthritis Using the Nationwide Readmission Database

    Ali Yazdanyar1, Anthony Donato 2, Kathleen McElwee 3, Mary Chester Wasko 4 and Michael Ward 5, 1Lehigh Valley Hospital- Cedar Crest, Allentown, PA, 2Reading Hospital, PA, Reading, 3Reading Hospital, Reading, PA, 4Allegheny Health Network-West Penn Hospital, Pittsburgh, PA, 5NIAMS, Bethesda, MD

    Background/Purpose: To assess the risk of 30-day readmission, mortality, and adverse events among adults with Rheumatoid Arthritis as compared to Osteoarthritis after primary hip or…
  • Abstract Number: 2503 • 2018 ACR/ARHP Annual Meeting

    Impact of Tobacco Smoking on 1-Year Mortality Following Total Hip and Total Knee Arthroplasty Among Rheumatoid Arthritis Patients – a Danish Cohort Study Using Nationwide Health Care Registers

    René Cordtz1,2, Laerke Bech-Illum3, Daniel Prieto-Alhambra4, Pil Hoejgaard3,5, Kristian Zobbe3,6, Nina Imbæk3 and Lene Dreyer7, 1Center for Rheumatology and Spine Diseases, Gentofte-Rigshospitalet, Hellerup, Denmark, 2The Parker Institute, Bispebjerg and Frederiksberg Hospital, The Capital Region of Denmark, Copenhagen, Denmark, 3Center for Rheumatology and Spine Diseases - Gentofte, Rigshospitalet, Hellerup, Denmark, 4Internal Medicine and Primary Care, URFOA-IMIM, Parc de Salut Mar; Idiap Jordi Gol i Gurina-Institut Català de la Salut; Oxford NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, UK, Barcelona, Spain, 5The Parker Institute, Bispebjerg and Frederiksberg Hospital, The Capital Region of Denmark, Denmark, 6The Parker Institute, Bispebjerg and Frederiksberg Hospital, Capital Region of Denmark, Copenhagen, Denmark, 7Departments of Rheumatology and Clinical Medicine, Aalborg University Hospital and Aalborg University, 9000 Aalborg, Denmark

    Background/Purpose: Tobacco smoking and rheumatoid arthritis (RA) are independent risk factors for short-term complications following total hip and total knee arthroplasty (THA/TKA). We aimed to…
  • Abstract Number: 1425 • 2015 ACR/ARHP Annual Meeting

    Current Tobacco Use and the Rates of Complications after Total Hip Arthroplasty

    Jasvinder A. Singh, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: The risk of postoperative complication with tobacco use disorder and complication after total hip arthroplasty (THA) are not known. Our objective was to compare…
  • Abstract Number: 1854 • 2014 ACR/ARHP Annual Meeting

    Systemic Lupus Erythematosus Patients Have Increased Risk of Short Term Adverse Events after Total Hip Arthroplasty

    Jordan Roberts1, Lisa A. Mandl2, Edwin Su3, David J. Mayman4, Mark P. Figgie4, Arielle Fein5, Yuo-Yu Lee5, Ummara Shah6 and Susan M. Goodman2, 1Weill Cornell Medical College, New York, NY, 2Rheumatology, Hospital for Special Surgery, New York, NY, 3Orthopedic Surgery, Hospital for Special Surgery, New York, NY, 4Orthopedics, Hospital for Special Surgery, New York, NY, 5Hospital for Special Surgery, New York, NY, 6Division of Rheumatology, New York University School of Medicine, NYC, NY

    Background/Purpose: Total Hip Arthroplasty (THA) is the most frequent orthopedic procedure performed in lupus (SLE) patients. Whether SLE patients have higher rates of complications after…
  • « Previous Page
  • 1
  • 2
  • 3
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology